JUBLPHARMA Expands US Manufacturing Footprint
JUBLPHARMA's subsidiary Jubilant HollisterStier has launched its third sterile fill & finish line at its Spokane (US) facility, adding 50% more capacity and starting revenue generation with its first production batch. 🚀
With a fourth line underway, the company is set to double its sterile injectable capacity, boosting US pharma resilience and reducing reliance on offshore supply chains.🌍
#WatchOutFor#StockInNews#FundamentalViews#HiddenGems#TrendingSectors
708 likes·66 comments

















